{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:56:33Z","timestamp":1789721793537,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s43032-023-01297-7","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T16:01:21Z","timestamp":1690646481000},"page":"291-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review"],"prefix":"10.1007","volume":"31","author":[{"given":"Isabela Landsteiner Sampaio","family":"Amendola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Spann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-4345","authenticated-orcid":false,"given":"Bhuchitra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","unstructured":"Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014. https:\/\/doi.org\/10.2147\/IJWH.S51083.","DOI":"10.2147\/IJWH.S51083"},{"key":"1297_CR2","doi-asserted-by":"publisher","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003. https:\/\/doi.org\/10.1067\/mob.2003.99.","DOI":"10.1067\/mob.2003.99"},{"key":"1297_CR3","doi-asserted-by":"publisher","unstructured":"Stewart EA. Uterine fibroids. Lancet. 2001. https:\/\/doi.org\/10.1016\/S0140-6736(00)03622-9.","DOI":"10.1016\/S0140-6736(00)03622-9"},{"key":"1297_CR4","doi-asserted-by":"publisher","unstructured":"Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012. https:\/\/doi.org\/10.1186\/1472-6874-12-6.","DOI":"10.1186\/1472-6874-12-6"},{"key":"1297_CR5","doi-asserted-by":"publisher","unstructured":"Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. 2014. https:\/\/doi.org\/10.1016\/j.ajog.2013.08.008.","DOI":"10.1016\/j.ajog.2013.08.008"},{"key":"1297_CR6","doi-asserted-by":"publisher","unstructured":"Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008. https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.01.008.","DOI":"10.1016\/j.bpobgyn.2008.01.008"},{"key":"1297_CR7","doi-asserted-by":"publisher","unstructured":"Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006. https:\/\/doi.org\/10.1016\/j.ajog.2006.02.020.","DOI":"10.1016\/j.ajog.2006.02.020"},{"key":"1297_CR8","doi-asserted-by":"publisher","unstructured":"Go VAA, Thomas MC, Singh B, Prenatt S, Sims H, Blanck JF, Segars JH. A systematic review of the psychosocial impact of fibroids before and after treatment. Am J Obstet Gynecol. 2020. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.044.","DOI":"10.1016\/j.ajog.2020.05.044"},{"key":"1297_CR9","doi-asserted-by":"publisher","unstructured":"K\u00e4mpj\u00e4rvi K, M\u00e4kinen N, Mehine M, et al. MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas. Br J Cancer. 2016. https:\/\/doi.org\/10.1038\/bjc.2016.130.","DOI":"10.1038\/bjc.2016.130"},{"key":"1297_CR10","doi-asserted-by":"publisher","unstructured":"M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Frizzell N, B\u00fctzow R, Vahteristo P. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer. 2017. https:\/\/doi.org\/10.1186\/s12943-017-0672-1.","DOI":"10.1186\/s12943-017-0672-1"},{"key":"1297_CR11","doi-asserted-by":"publisher","unstructured":"Mehine M, Kaasinen E, Heinonen H-R, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A. 2016. https:\/\/doi.org\/10.1073\/pnas.1518752113.","DOI":"10.1073\/pnas.1518752113"},{"key":"1297_CR12","doi-asserted-by":"publisher","unstructured":"Kampjarvi K, Makinen N, Kilpivaara O, et al. Somatic MED12 mutations in uterine and colorectal cancer. Br J Cancer. 2012. https:\/\/doi.org\/10.1038\/bjc.2012.428.","DOI":"10.1038\/bjc.2012.428"},{"key":"1297_CR13","doi-asserted-by":"publisher","unstructured":"Perot G, Croce S, Ribeiro A, et al. MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0040015.","DOI":"10.1371\/journal.pone.0040015"},{"key":"1297_CR14","doi-asserted-by":"publisher","unstructured":"Croce S, Chibon F. MED12 and uterine smooth muscle oncogenesis: state of the art and perspectives. Eur J of Can. 2015. https:\/\/doi.org\/10.1016\/j.ejca.2015.04.023.","DOI":"10.1016\/j.ejca.2015.04.023"},{"key":"1297_CR15","doi-asserted-by":"publisher","unstructured":"Taatjes DJ. The human mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci. 2010. https:\/\/doi.org\/10.1016\/j.tibs.2010.02.004.","DOI":"10.1016\/j.tibs.2010.02.004"},{"key":"1297_CR16","doi-asserted-by":"publisher","unstructured":"Mehine M, Kaasinen E, M\u00e4kinen N, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013. https:\/\/doi.org\/10.1056\/NEJMoa1302736.","DOI":"10.1056\/NEJMoa1302736"},{"key":"1297_CR17","doi-asserted-by":"publisher","unstructured":"Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA. 2015. https:\/\/doi.org\/10.1001\/jama.2015.3656.","DOI":"10.1001\/jama.2015.3656"},{"key":"1297_CR18","doi-asserted-by":"publisher","unstructured":"Schwetye KE, Pfeifer JD, Duncavage EJ. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Hum Pathol. 2014. https:\/\/doi.org\/10.1016\/j.humpath.2013.08.005.","DOI":"10.1016\/j.humpath.2013.08.005"},{"key":"1297_CR19","doi-asserted-by":"publisher","unstructured":"Lee M, Cheon K, Chae B, et al. Analysis of MED12 mutation in multiple uterine leiomyomas in South Korean patients. Int J Med Sci. 2018. https:\/\/doi.org\/10.7150\/ijms.21856.","DOI":"10.7150\/ijms.21856"},{"key":"1297_CR20","doi-asserted-by":"publisher","unstructured":"Ko YA, Jamaluddin MFB, Adebayo M, et al. Extracellular matrix (ECM) activates \u03b2-catenin signaling in uterine fibroids. Reproduction. 2018. https:\/\/doi.org\/10.1530\/REP-17-0339.","DOI":"10.1530\/REP-17-0339"},{"key":"1297_CR21","doi-asserted-by":"publisher","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, Kaasinen E, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011. https:\/\/doi.org\/10.1126\/science.1208930.","DOI":"10.1126\/science.1208930"},{"key":"1297_CR22","doi-asserted-by":"publisher","unstructured":"Ajabnoor GMA, Mohammed NA, Banaganapalli B, et al. Expanded somatic mutation spectrum of MED12 gene in uterine leiomyomas of Saudi Arabian women. Front Genet 2018. https:\/\/doi.org\/10.3389\/fgene.2018.00552.","DOI":"10.3389\/fgene.2018.00552"},{"issue":"12","key":"1297_CR23","first-page":"1099","volume":"7","author":"A-R Ahmadi","year":"2015","unstructured":"Ahmadi A-R, Porrahim H, Moghadasi H, Najafi N, Rakhshan A. MED12 exon 2 mutations in uterine leiomyoma\u2019s in women patients of Tehran Province of Iran. J Pharm Sci Res. 2015;7(12):1099\u2013102.","journal-title":"J Pharm Sci Res"},{"key":"1297_CR24","doi-asserted-by":"publisher","unstructured":"Di Tommaso S, Tinelli A, Malvasi A, Massari S. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Mol Hum Reprod. 2014. https:\/\/doi.org\/10.1093\/molehr\/gau055.","DOI":"10.1093\/molehr\/gau055"},{"key":"1297_CR25","doi-asserted-by":"publisher","unstructured":"El Andaloussi A, Al-Hendy A, Ismail N, Boyer TG, Halder SK. Introduction of somatic mutation in MED12 induces Wnt4\/\u03b2-catenin and disrupts autophagy in human uterine myometrial cell. Reprod Sci. 2020. https:\/\/doi.org\/10.1007\/s43032-019-00084-7.","DOI":"10.1007\/s43032-019-00084-7"},{"key":"1297_CR26","doi-asserted-by":"publisher","unstructured":"Fazeli E, Piltan S, Gholami M, et al. CYP24A1 expression analysis in uterine leiomyoma regarding MED12 mutation profile. Arch Gynecol Obstet. 2021. https:\/\/doi.org\/10.1007\/s00404-020-05825-7.","DOI":"10.1007\/s00404-020-05825-7"},{"key":"1297_CR27","doi-asserted-by":"publisher","unstructured":"Galindo LJ, Hern\u00e1ndez-Beeftink T, Salas A, et al. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol Oncol. 2018. https:\/\/doi.org\/10.1016\/j.ygyno.2018.07.007.","DOI":"10.1016\/j.ygyno.2018.07.007"},{"key":"1297_CR28","doi-asserted-by":"publisher","unstructured":"Halder SK, Laknaur A, Miller J, Layman LC, Diamond M, Al-Hendy A. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Mol Genet Genomics. 2015. https:\/\/doi.org\/10.1007\/s00438-014-0938-x.","DOI":"10.1007\/s00438-014-0938-x"},{"key":"1297_CR29","doi-asserted-by":"publisher","unstructured":"Hayden MA, Ordulu Z, Gallagher CS, et al. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer genetics. 2018. https:\/\/doi.org\/10.1016\/j.cancergen.2018.01.001.","DOI":"10.1016\/j.cancergen.2018.01.001"},{"key":"1297_CR30","doi-asserted-by":"publisher","unstructured":"Jamaluddin MFB, Ko YA, Kumar M, et al. Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein periostin. Endocrinology. 2018. https:\/\/doi.org\/10.1210\/en.2017-03018.","DOI":"10.1210\/en.2017-03018"},{"key":"1297_CR31","doi-asserted-by":"publisher","unstructured":"Je EM, Kim MR, Min KO, Yoo NJ, Lee SH. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer. 2012. https:\/\/doi.org\/10.1002\/ijc.27610.","DOI":"10.1002\/ijc.27610"},{"key":"1297_CR32","doi-asserted-by":"publisher","unstructured":"M\u00e4kinen N, Heinonen H-R, Moore S, Tomlinson IPM, Van der Spuy ZM, Aaltonen LA. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2011. https:\/\/doi.org\/10.18632\/oncotarget.370.","DOI":"10.18632\/oncotarget.370"},{"key":"1297_CR33","doi-asserted-by":"publisher","unstructured":"Markowski DN, Bartnitzke S, L\u00f6ning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids\u2014their relationship to cytogenetic subgroups. Int J Cancer. 2012. https:\/\/doi.org\/10.1002\/ijc.27424.","DOI":"10.1002\/ijc.27424"},{"key":"1297_CR34","doi-asserted-by":"publisher","unstructured":"Matsubara A, Sekine S, Yoshida M, et al. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology. 2013. https:\/\/doi.org\/10.1111\/his.12039.","DOI":"10.1111\/his.12039"},{"key":"1297_CR35","doi-asserted-by":"publisher","unstructured":"McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0033251.","DOI":"10.1371\/journal.pone.0033251"},{"key":"1297_CR36","doi-asserted-by":"publisher","unstructured":"Park MJ, Shen H, Kim NH, et al. Mediator kinase disruption in MED12-mutant uterine fibroids from Hispanic women of South Texas. J Clin Endocrinol Metab. 2018. https:\/\/doi.org\/10.1210\/jc.2018-00863.","DOI":"10.1210\/jc.2018-00863"},{"key":"1297_CR37","doi-asserted-by":"publisher","unstructured":"Sadeghi S, Khorrami M, Amin-Beidokhti M, et al. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Tumour Biol. 2016. https:\/\/doi.org\/10.1007\/s13277-015-3943-8.","DOI":"10.1007\/s13277-015-3943-8"},{"issue":"8","key":"1297_CR38","first-page":"2441","volume":"5","author":"S Shahbazi","year":"2015","unstructured":"Shahbazi S, Fatahi N, Amini-Moghaddam S. Somatic mutational analysis of MED12 exon 2 in uterine leiomyomas of Iranian women. Am J Cancer Res. 2015;5(8):2441\u20136.","journal-title":"Am J Cancer Res."},{"key":"1297_CR39","doi-asserted-by":"publisher","unstructured":"Turunen M, Spaeth JM, Keskitalo S, et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep. 2014. https:\/\/doi.org\/10.1016\/j.celrep.2014.03.047.","DOI":"10.1016\/j.celrep.2014.03.047"},{"key":"1297_CR40","doi-asserted-by":"publisher","unstructured":"Wu J, Zou Y, Luo Y, et al. Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma. Oncol Lett. 2017. https:\/\/doi.org\/10.3892\/ol.2017.6120.","DOI":"10.3892\/ol.2017.6120"},{"key":"1297_CR41","doi-asserted-by":"publisher","unstructured":"Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;2011 https:\/\/doi.org\/10.1016\/j.fertnstert.2011.03.079.","DOI":"10.1016\/j.fertnstert.2011.03.079"},{"key":"1297_CR42","doi-asserted-by":"publisher","unstructured":"Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest. 2015. https:\/\/doi.org\/10.1172\/JCI81534.","DOI":"10.1172\/JCI81534"},{"key":"1297_CR43","doi-asserted-by":"publisher","unstructured":"Bateman NW, Tarney CM, Abulez TS, et al. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. iScience. 2021. https:\/\/doi.org\/10.1016\/j.isci.2021.103665.","DOI":"10.1016\/j.isci.2021.103665"},{"key":"1297_CR44","doi-asserted-by":"publisher","unstructured":"George JW, Fan H, Johnson B, et al. Integrated epigenome, exome, and transcriptome analyses reveal molecular subtypes and homeotic transformation in uterine fibroids. Cell Rep. 2019. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.077.","DOI":"10.1016\/j.celrep.2019.11.077"},{"key":"1297_CR45","doi-asserted-by":"publisher","unstructured":"Catherino WH, Eltoukhi HM, Al-Hendy A. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med. 2013. https:\/\/doi.org\/10.1055\/s-0033-1348896.","DOI":"10.1055\/s-0033-1348896"},{"key":"1297_CR46","doi-asserted-by":"publisher","unstructured":"Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H, Mittal K. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod. 2005. https:\/\/doi.org\/10.1093\/humrep\/dei309.","DOI":"10.1093\/humrep\/dei309"},{"key":"1297_CR47","doi-asserted-by":"publisher","unstructured":"Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in Black Americans. Fertil Steril. 2006. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.01.052.","DOI":"10.1016\/j.fertnstert.2006.01.052"},{"key":"1297_CR48","doi-asserted-by":"publisher","unstructured":"Bertsch E, Qiang W, Zhang Q, et al. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol. 2014. https:\/\/doi.org\/10.1038\/modpathol.2013.243.","DOI":"10.1038\/modpathol.2013.243"},{"key":"1297_CR49","doi-asserted-by":"publisher","unstructured":"Mas A, Cervell\u00f3 I, Fern\u00e1ndez-\u00c1lvarez A, et al. Overexpression of the truncated form of high mobility group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation. Mol Hum Reprod. 2015. https:\/\/doi.org\/10.1093\/molehr\/gau114.","DOI":"10.1093\/molehr\/gau114"},{"key":"1297_CR50","doi-asserted-by":"publisher","unstructured":"Lyon MF. X-chromosome inactivation. Curr Biol 1999. https:\/\/doi.org\/10.1016\/s0960-9822(99)80151-1.","DOI":"10.1016\/s0960-9822(99)80151-1"},{"key":"1297_CR51","doi-asserted-by":"publisher","unstructured":"Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005. https:\/\/doi.org\/10.1038\/nrc1692.","DOI":"10.1038\/nrc1692"},{"key":"1297_CR52","doi-asserted-by":"publisher","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002. https:\/\/doi.org\/10.1038\/nrc839.","DOI":"10.1038\/nrc839"},{"key":"1297_CR53","doi-asserted-by":"publisher","unstructured":"Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001. https:\/\/doi.org\/10.1038\/35077225.","DOI":"10.1038\/35077225"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-023-01297-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-023-01297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:12:15Z","timestamp":1706638335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-023-01297-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s43032-023-01297-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}